1. Home
  2. MRVI vs RMNI Comparison

MRVI vs RMNI Comparison

Compare MRVI & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • RMNI
  • Stock Information
  • Founded
  • MRVI 2014
  • RMNI 2005
  • Country
  • MRVI United States
  • RMNI United States
  • Employees
  • MRVI N/A
  • RMNI N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • RMNI Business Services
  • Sector
  • MRVI Health Care
  • RMNI Consumer Discretionary
  • Exchange
  • MRVI Nasdaq
  • RMNI Nasdaq
  • Market Cap
  • MRVI 449.6M
  • RMNI 414.5M
  • IPO Year
  • MRVI 2020
  • RMNI N/A
  • Fundamental
  • Price
  • MRVI $3.69
  • RMNI $3.89
  • Analyst Decision
  • MRVI Buy
  • RMNI Strong Buy
  • Analyst Count
  • MRVI 7
  • RMNI 3
  • Target Price
  • MRVI $4.54
  • RMNI $5.67
  • AVG Volume (30 Days)
  • MRVI 1.6M
  • RMNI 379.3K
  • Earning Date
  • MRVI 11-06-2025
  • RMNI 10-30-2025
  • Dividend Yield
  • MRVI N/A
  • RMNI N/A
  • EPS Growth
  • MRVI N/A
  • RMNI N/A
  • EPS
  • MRVI N/A
  • RMNI 0.47
  • Revenue
  • MRVI $192,435,000.00
  • RMNI $425,959,000.00
  • Revenue This Year
  • MRVI N/A
  • RMNI N/A
  • Revenue Next Year
  • MRVI $7.27
  • RMNI $3.12
  • P/E Ratio
  • MRVI N/A
  • RMNI $8.07
  • Revenue Growth
  • MRVI N/A
  • RMNI N/A
  • 52 Week Low
  • MRVI $1.67
  • RMNI $1.95
  • 52 Week High
  • MRVI $6.21
  • RMNI $5.38
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 61.86
  • RMNI 40.66
  • Support Level
  • MRVI $3.37
  • RMNI $3.65
  • Resistance Level
  • MRVI $3.76
  • RMNI $3.93
  • Average True Range (ATR)
  • MRVI 0.25
  • RMNI 0.17
  • MACD
  • MRVI 0.05
  • RMNI 0.01
  • Stochastic Oscillator
  • MRVI 94.02
  • RMNI 43.87

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.

Share on Social Networks: